In the news | 1st Feb 2022
What’s in Store for 2022? Our Experts Weigh in
Around this time last year, the first COVID-19 vaccines were authorized for emergency use by organizations such as the FDA, the EMA, the MHRA and many more internationally. A year before that, COVID-19 had not yet been declared a pandemic. It goes to show how much can change in this industry, as well as how important this sector is. With what we know – having adapted constantly since March 2020 and having also experienced uncertainty as new variants are discovered – predictions from industry experts for 2022 are important and illuminating.
Hear from experts, including Alberto Pascual, in this article, published in Drug Discovery World.